Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
NCT ID: NCT06757725
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2022-09-03
2023-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
NCT06631404
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851
Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
NCT06796569
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
NCT06287125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with lupus nephritis
Theses are 25 patients diagnosed with lupus nephritis
colour doppler of the renal artery and measurement of resistive index
using colour doppler to asses vascular resistance and resistive index
Lupus without nephritis
Theses are 25 patients diagnosed with lupus without evidence of nephritis
colour doppler of the renal artery and measurement of resistive index
using colour doppler to asses vascular resistance and resistive index
Healthy control
Patients who are healthy volunteers with no evidence of nephritis or systemic lupus
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colour doppler of the renal artery and measurement of resistive index
using colour doppler to asses vascular resistance and resistive index
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarek Samy Abdelaziz
Associate professor of Internal medicine and nephrology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University Hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-632-2022
Identifier Type: OTHER
Identifier Source: secondary_id
MS-632-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.